Fate Therapeutics (FATE) Total Debt (2012 - 2019)

Fate Therapeutics' Total Debt history runs 8 years deep, the most recent figure standing at $13.9 million for Q3 2019.

• Quarterly Total Debt fell 6.28% year-over-year to $13.9 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $13.9 million (down 6.28% YoY) and the FY2018 annual result came in at $14.9 million, up 0.51% from the prior year.
• Total Debt was $13.9 million for Q3 2019 at Fate Therapeutics, down from $14.9 million in the prior quarter.
• Across five years, Total Debt topped out at $19.7 million in Q2 2015 and bottomed at $6.7 million in Q2 2017.
• A 5-year average of $15.1 million and a median of $14.9 million in 2018 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2015 — Total Debt surged 2540.08% — and 2017, when it tumbled 54.41%.
• Fate Therapeutics' Total Debt stood at $18.4 million in 2015, then tumbled by 41.84% to $10.7 million in 2016, then soared by 38.55% to $14.8 million in 2017, then increased by 0.51% to $14.9 million in 2018, then declined by 6.4% to $13.9 million in 2019.
• Business Quant data shows FATE's Total Debt at $13.9 million in Q3 2019, $14.9 million in Q2 2019, and $14.9 million in Q1 2019.